Precision Medicine via Diagnostic Enzyme Activity Testing

Project description

A novel assay will test an individual's rate of drug clearance to enable precise dosing

In 2018 alone, more than 100 new therapeutic drugs were approved in the EU and US. From over-the-counter treatments for headache to sophisticated targeted treatments requiring prescriptions, drugs must combine just the right synthesis of ingredients to combat what ails us. However, effective treatment relies equally on 'how much' as it does on 'what', and that varies from person to person based on a multitude of factors. One of the most important is how fast a drug is 'cleared' by the body. PreMeDosE is developing a nearly universal enzyme assay to test the activity level of the enzyme responsible for clearing most therapeutics. It will provide clinicians with critical information for truly personalised dosing.

Fields of science

Host institution

HELSINGIN YLIOPISTO

Net EU contribution

€ 150 000,00

Address

Yliopistonkatu 3
00014 Helsingin Yliopisto
Finland

Region

Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa

Activity type

Higher or Secondary Education Establishments

Links

Contact the organisation Website

Participation in EU R&I programmes

HORIZON collaboration network

Other funding

No data

Beneficiaries (1)